COSCIENS Biopharma Appoints Anna Biehn as Chief Executive Officer
PUBLIC · CSCIFApr 14, 2025
Position
Chief Executive Officer
Company
COSCIENS Biopharma
Anna Biehn
TorontoBiotechnologyHealthcareHealth Care
Description
COSCIENS Biopharma has announced the appointment of Anna Biehn as the new Chief Executive Officer, effective May 5, 2025. Biehn brings over 25 years of experience in consumer products and biosciences, following her role as Chief Financial Officer at NuTek Natural Ingredients.
Who to call at COSCIENS Biopharma, and when
A new leader at COSCIENS Biopharma brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day COSCIENS Biopharma raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at COSCIENS Biopharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at COSCIENS Biopharma. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
COSCIENS Biopharma
Location
Toronto, Ontario, Canada
About
COSCIENS Biopharma Inc. (NASDAQ: CSCI) is a life science company specializing in developing cosmeceutical, nutraceutical, and pharmaceutical products. They aim to enhance health and wellness through innovative natural-based solutions. The company focuses on leveraging its portfolio and technologies for significant innovation and market growth.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment COSCIENS Biopharma changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.